FDA Seizes ₹7.26 Lakh Patanjali Divya Pharmacy Stock in Nagpur — Katol Road Outlet Raided Over Misleading Ads
Published: May 29, 2026 | Category: Nagpur Local | By: Nagpur Updates Desk
Maharashtra’s Food and Drug Administration (FDA) has seized medicines worth ₹7,26,655 from a Patanjali-affiliated Divya Pharmacy outlet on Katol Road, Nagpur — acting on directions from FDA Commissioner Tukaram Mundhe.
The raid is part of a statewide crackdown that seized medicines worth ₹73.24 lakh across seven Maharashtra divisions in a single day.
What Was Seized — and Where?
| Detail | Information |
|---|---|
| Location raided | Divya Pharmacies franchise, Katol Road, near Kamptee Chowk, Nagpur |
| Date of raid | Friday, May 29, 2026 |
| Value seized | ₹7,26,655 |
| Action ordered by | FDA Commissioner Tukaram Mundhe |
| Legal basis | Drugs and Magic Remedies (Objectionable Advertisements) Act |
| Executing team | FDA Nagpur Division |
The team seized stocks of multiple Divya Pharma products — including Nutrigold, Nempfit, Mupivit, Melastipt, and Sirctipt — totalling ₹7,26,655.
Why Were These Products Seized?
The action was triggered by packaging and promotional material that made unsubstantiated claims about ailments and treatments in violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act.
In simple terms — the products were claiming to cure or treat specific diseases without proper scientific evidence or regulatory approval for those claims. This is a long-standing issue with Patanjali and Divya Pharmacy products — and one that has been litigated even at the Supreme Court of India level.
The Bigger Picture: ₹73.24 Lakh Seized Across Maharashtra
The Nagpur raid was not a standalone action. Simultaneous raids were carried out across Mumbai, Konkan, Pune, Nashik, Amravati, Nagpur and Chhatrapati Sambhajinagar divisions under the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act.
Division-wise seizures:
- Nagpur: ₹7,26,655
- Nashik: ₹7,10,945
- Pune: ₹14.68 lakh
- Konkan: ₹18.58 lakh
- Total across Maharashtra: ₹73.24 lakh
This coordinated, simultaneous multi-city operation signals that FDA Commissioner Tukaram Mundhe is running a systematic, intelligence-led campaign — not ad hoc raids.
Who Is Tukaram Mundhe — and Why Is This Significant?
FDA Commissioner Tukaram Mundhe is one of Maharashtra’s most action-oriented IAS officers. Since assuming office, he has ordered multiple raids across Maharashtra targeting food adulteration, illegal sale of banned products, suspected substandard goods, and violations of FDA regulations. Within days of his appointment, FDA teams conducted dozens of raids across Mumbai, Pune, Nashik, Nagpur, Amravati and other regions, resulting in seizures, arrests and the sealing of several establishments.
Under his direction, the FDA has been operating with unusual speed and scale — a sharp departure from the traditionally slow pace of regulatory action.
What Is Divya Pharmacy?
Divya Pharmacy is the retail arm of Baba Ramdev’s Patanjali group. It manufactures and sells Ayurvedic and herbal products — primarily through its own pharmacy outlets and franchise stores across India.
Patanjali and Divya Pharmacy have a history of regulatory action over misleading advertisements. The Supreme Court has repeatedly pulled up the company for making unverified claims — including that its products can cure diabetes, blood pressure, arthritis, and other serious conditions.
What Is the Drugs and Magic Remedies Act?
The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisements of drugs or remedies that claim to:
- Cure specific diseases without proven efficacy
- Guarantee results that are not scientifically verified
- Misrepresent the nature or quality of a product
Violation of this Act can result in:
- Seizure of the products
- Cancellation of the manufacturing/selling licence
- Criminal prosecution of the company and its officers
- Heavy fines
Q: Can I still buy Patanjali products from other Nagpur outlets? The raid targeted this specific Katol Road franchise for specific products. Other Patanjali outlets in Nagpur are not necessarily affected. However, consumers should check product labels and avoid products that make disease-cure claims.
Q: Are the seized products harmful? The seizure was for misleading advertising — not for product safety violations. The products are not necessarily dangerous — the issue is that their promotional claims are unverified.
Q: What should I do if I have already bought these products? If you have purchased Nutrigold, Nempfit, Mupivit, Melastipt, or Sirctipt based on specific disease-cure claims, you may want to consult a doctor rather than relying on those claims for treatment.
Q: Can I file a consumer complaint against misleading medicine ads? Yes — file a complaint with the National Consumer Disputes Redressal Commission (NCDRC) online at edaakhil.nic.in, or approach your local Consumer Forum.
Q: Will Patanjali face criminal action? The current action involves seizure under the Drugs and Magic Remedies Act. Criminal prosecution depends on the outcome of the investigation. If violations are confirmed, the FDA can file a case.
What This Means for Nagpur Consumers
This raid is a reminder that regulatory packaging claims must be taken with caution — particularly for products that promise to cure or treat medical conditions.
As a consumer in Nagpur, here are simple protective steps:
- Check FSSAI/CDSCO approvals on medicine packaging
- Avoid products that claim to cure specific diseases without a doctor’s prescription
- Report misleading ads to the FDA on its helpline or website: fda.maharashtra.gov.in
- Consult a doctor before taking any Ayurvedic medicine for a serious health condition
Nagpur Updates will follow the investigation and report further action taken by the FDA in this case.
Tags: FDA Nagpur, Patanjali Raid, Divya Pharmacy, Tukaram Mundhe, Misleading Ads, Drugs Magic Remedies Act, Nagpur Health News, Maharashtra FDA, Nagpur Local News 2026
